Previous studies have reported that OI patients with COL1A1 haploinsufficiency mutations have milder bone fragility and damage than those with COL1A1/COL1A2 helical glycine mutations [7, 8]. The gene discussed is COL1A2; the disease is osteogenesis imperfecta.